[1]
2021. FAVIPIRAVIR THERAPY FOR PATIENTS WITH COVID-19 PNEUMONIA: AN OBSERVATIONAL STUDY: Supawadee Suppadungsuk1 , Thananya Wongsinin1 , Sirawat Srichatrapimuk1 , Suppachok Kirdlarp1,2, Kulapong Jayanama1 , Kanin Thammavaranucupt1 , Dhanesh Pitidhammabhorn1 , Sithakom Phusanti1 , Nithita Nanthatanti1 and Somnuek Sungkanuparph1. The Southeast Asian Journal of Tropical Medicine and Public Health. 52, 1 (Oct. 2021), 161–174.